Ohio Trade Zone Gets New Manager in Quiet Handover

2026-20774, Foreign-Trade Zone (FTZ) 16, Notification of Proposed Production Activity; Yazaki North America, Inc.; (Stamped Copper Terminals); Petoskey, Michigan

Yazaki North America wants to start making stamped copper terminals at their Petoskey, Michigan plant using special foreign materials with lower or no import duties. This change could save money on materials like copper and steel alloys, but some parts still face tariffs. People have until November 18, 2026, to share their thoughts before the plan gets the green light.

2026-20776, Foreign-Trade Zone (FTZ) 50, Notification of Proposed Production Activity; Sanyo Denki America, Inc.; (Cooling, Servo, and Power Systems and Assemblies); Torrance, California

Sanyo Denki America in Torrance, California, wants to start making cooling, servo, and power system parts inside Foreign-Trade Zone 50. This means they can use certain imported materials with lower or no import taxes, helping them save money and speed up production. The government is reviewing this plan, which could boost local manufacturing and keep prices competitive.

2026-20775, Foreign-Trade Zone (FTZ) 40, Notification of Proposed Production Activity; Norman Noble Company Inc.; (Implantable Medical Devices); Highland Heights, Ohio

Norman Noble Company in Highland Heights, Ohio, wants to start making implantable medical devices using some imported materials with special trade benefits under Foreign-Trade Zone 40. This move could save money on import duties for parts like tungsten plates and stainless steel tubes. Public comments are open until November 18, 2026, so anyone interested can share their thoughts before the plan moves forward.

2026-20253, Foreign-Trade Zone (FTZ) 75; Authorization of Production Activity; Essai, Inc.; (Semiconductor Test Equipment); Chandler, Arizona

Essai, Inc. in Chandler, Arizona, got the green light to make semiconductor test equipment inside Foreign-Trade Zone 75. This means they can produce their high-tech gear with special trade benefits, helping them save money and speed up operations. The approval was finalized on September 28, 2026, so Essai can start or continue their work without any extra delays.

2026-20254, Foreign-Trade Zone (FTZ) 45; Authorization of Limited Production Activity; Qorvo US, Inc.; (Semiconductor Wafers and Modules); Hillsboro, Oregon

Qorvo US, Inc. in Hillsboro, Oregon got the green light to start limited production of semiconductor wafers and modules in Foreign-Trade Zone 45. This means they can use some imported parts with special rules for two years, helping them save money and speed up manufacturing. The approval came after a careful review and public input, so it’s official and ready to roll!

2026-20261, Foreign-Trade Zone (FTZ) 153; Authorization of Limited Production Activity; CMS Circuits, Inc.; (Electronic Manufacturing Services in Aerospace, Industrial, and Medical Applications); Murrieta, California

CMS Circuits, Inc. in Murrieta, California, got the green light to start limited production of electronic parts for aerospace, industrial, and medical uses inside Foreign-Trade Zone 153. This means they can bring in certain fiber optic bundles under special foreign status, but only for two years. The City of San Diego and local businesses will benefit from this move, which could boost local manufacturing and trade.

Previous: 2026-10867, Diffusion-Annealed, Nickel-Plated Flat-Rolled Steel Products From Japan: Notice of Court Decision Not in Harmony With the Results of Antidumping Administrative Review; Notice of Amended Final Results

The U.S. Court of International Trade changed the antidumping duty results for nickel-plated steel products from Japan, specifically affecting Toyo Kohan Co., Ltd. This means the Department of Commerce is updating the final duty rates for Toyo Kohan based on the court’s decision, starting June 1, 2026. If you’re involved in importing these steel products, keep an eye on these new numbers—they could impact costs and trade moves.

Next: 2026-10873, Oncology Pharmaceuticals: Streamlined Nonclinical Safety Studies for Biologics and Conjugated Products; Draft Guidance for Industry; Availability

The FDA is rolling out a new draft guide to help cancer drug makers speed up safety testing for biologic and conjugated medicines. This plan cuts down on extra animal testing and uses smarter methods learned during the COVID-19 pandemic. Drug developers should send their feedback by July 31, 2026, to shape the final rules and save time and money in bringing new cancer treatments to patients.